Cookies on Pinsent Masons website

Our website uses cookies and similar technologies to allow us to promote our services and enhance your browsing experience. If you continue to use our website you agree to our use of cookies.

To understand more about how we use cookies, or for information on how to change your cookie settings, please see our Cookie Policy.

Life-Lines - Life Sciences through a legal lens

This week we look at a range of topics including the UK Government's 'serious shortage protocol', its critics and the court challenges.

Other highlights in this issue include:

  • EU court limits pharma's scope for patentextensions
  • UK court refuses judicial review and reference to CJEU in Orion case
  • Tribunal considers ICO's information notice powers under GDPR
  • ICOS patent for a Tadalafil dosing regime invalid
  • Hancock seeks reforms to genetic data use and commercial genomic testing
  • CMA ends Remicade investigation
  • Boardroom Briefing April 2019
  • EU MDR/IVDR Coordination Group seeks clarification of expert panel exemptions
  • England moves to opt out organ donation
  • EMA's annual report on Eudravigilance
  • EMA report on 20 years of sampling and testing CAPs
  • UK Government's 'serious shortage protocol' gets the nod but challenges continue

Brexit

  • Where we are (as at 26 March 2019)
  • Report: How are the EU institutions and European countries preparing for Brexit?
  • No-deal handbook: A practical guide to preparing for a possible no-deal Brexit
  • Brexit - preparing for a No Deal Brexit: Videos and Webinar
  • MHRA guidance and publications on a possible no deal scenario
  • EU actions to prevent medicine shortages due to Brexit
  • The Conformity Assessment (Mutual Recognition Agreements) Regulations 2019

Webinars and seminars

Key Contacts